Literature DB >> 12860195

Antimicrobial peptides in the first line defence of human colon mucosa.

Maria Tollin1, Peter Bergman, Torgny Svenberg, Hans Jörnvall, Gudmundur Hrafn Gudmundsson, Birgitta Agerberth.   

Abstract

Antimicrobial peptides and proteins are effector molecules in the protection of epithelial surfaces. We have evaluated the presence of antimicrobial peptides/proteins that can participate in human colonic defence against microbes. A peptide/protein extract of normal human colon mucosa was found to be active against Gram-positive bacteria, Gram-negative bacteria, and fungi. Four polypeptides with antimicrobial activity were isolated from this material and they were identified by N-terminal amino acid sequence analysis as ubiquicidin, histone H2B, eosinophil cationic protein, and phospholipase A(2) (PLA(2)). Using immunodetection and mass spectrometry, LL-37, HNP1-3, and HBD-1 were also identified. Combined, these results indicate that the colon mucosa is protected by a complex mixture of polypeptides, able to kill invading microbes and working in synergy as a barrier against bacterial invasion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860195     DOI: 10.1016/s0196-9781(03)00114-1

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  46 in total

Review 1.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 2.  Whipple's disease: a macrophage disease.

Authors:  Benoît Desnues; Melanie Ihrig; Didier Raoult; Jean-Louis Mege
Journal:  Clin Vaccine Immunol       Date:  2006-02

Review 3.  On the physiology and pathophysiology of antimicrobial peptides.

Authors:  Roland Pálffy; Roman Gardlík; Michal Behuliak; Ludevit Kadasi; Jan Turna; Peter Celec
Journal:  Mol Med       Date:  2008-11-10       Impact factor: 6.354

4.  Molecular cloning of cecropin B responsive endonucleases in Yersinia ruckeri.

Authors:  Ulysses W Sallum; Thomas T Chen
Journal:  Mar Biotechnol (NY)       Date:  2010-03-30       Impact factor: 3.619

5.  Functional synergy between antimicrobial peptoids and peptides against Gram-negative bacteria.

Authors:  Nathaniel P Chongsiriwatana; Modi Wetzler; Annelise E Barron
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

Review 6.  Inflammatory bowel disease: an impaired barrier disease.

Authors:  Simon Jäger; Eduard F Stange; Jan Wehkamp
Journal:  Langenbecks Arch Surg       Date:  2012-11-18       Impact factor: 3.445

7.  Radiolabeling and Preliminary Evaluation of Ga-68 Labeled NODAGA-Ubiquicidin Fragments for Prospective Infection Imaging.

Authors:  Jyotsna Bhatt; Archana Mukherjee; Aruna Korde; Mukesh Kumar; Haladhar Dev Sarma; Ashutosh Dash
Journal:  Mol Imaging Biol       Date:  2017-02       Impact factor: 3.488

8.  Association between preoperative 25-hydroxyvitamin D level and hospital-acquired infections following Roux-en-Y gastric bypass surgery.

Authors:  Sadeq A Quraishi; Edward A Bittner; Livnat Blum; Mathew M Hutter; Carlos A Camargo
Journal:  JAMA Surg       Date:  2014-02       Impact factor: 14.766

Review 9.  Intestinal barrier in inflammatory bowel disease.

Authors:  Lena Antoni; Sabine Nuding; Jan Wehkamp; Eduard F Stange
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

10.  Bacterial Periplasmic Oxidoreductases Control the Activity of Oxidized Human Antimicrobial β-Defensin 1.

Authors:  J Wendler; D Ehmann; L Courth; B O Schroeder; N P Malek; J Wehkamp
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.